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SUMMARY
The terminal stages of neuronal degeneration
and death in neurodegenerative diseases remain
elusive. Autophagy is an essential catabolic pro-
cess frequently failing in neurodegeneration. Selec-
tive autophagy routes have recently emerged,
including nucleophagy, defined as degradation of
nuclear components by autophagy. Here, we
show that, in a mouse model for the polyglut-
amine disease dentatorubral-pallidoluysian atrophy
(DRPLA), progressive acquirement of an ataxic
phenotype is linked to severe cerebellar cellular pa-
thology, characterized by nuclear degeneration
through nucleophagy-based LaminB1 degradation
and excretion. We find that canonical autophagy
is stalled in DRPLA mice and in human fibroblasts
from patients of DRPLA. This is evidenced by
accumulation of p62 and downregulation of LC3-
I/II conversion as well as reduced Tfeb expression.
Chronic autophagy blockage in several conditions,
including DRPLA and Vici syndrome, an early-onset
autolysosomal pathology, leads to the activation of
alternative clearance pathways including Golgi
membrane-associated and nucleophagy-based
LaminB1 degradation and excretion. The combina-
tion of these alternative pathways and canonical
autophagy blockade, results in dramatic nuclear
pathology with disruption of the nuclear organiza-
tion, bringing about terminal cell atrophy and
degeneration. Thus, our findings identify a novel
progressive mechanism for the terminal phases of
neuronal cell degeneration and death in human
neurodegenerative diseases and provide a link be-
tween autophagy block, activation of alternative
pathways for degradation, and excretion of cellular
components.
INTRODUCTION
Nuclear homeostasis has recently been the focus of attention in
aggregation-prone neurodegenerative disorders. In particular,
defects in nucleo-cytoplasmic transport and deregulation of nu-
clear matrix have been identified as potential pathomechanisms
in several conditions [1–4]. Mutation in genes encoding nuclear
lamina constituents have been associated with degradation of
nuclear components by autophagy [5], in a process further
defined as nucleophagy.
Autophagy affects onset and progression of several human
neurodegenerative diseases, reflecting its key role as a
regulator of neuronal proteostasis and organelle quality con-
trol [6]. Bulk or selected cargos are recruited by autophagy
receptors, like p62, to forming double-membrane vesicles,
the autophagosomes, marked by the lipid-conjugated form
of LC3, LC3-II. Mature autophagosomes fuse with lysosomes
to form autolysosomes where the cargo is digested by lyso-
somal enzymes and basic molecules are recycled back to
the cytoplasm [7]. Nucleophagy, a selective autophagy mech-
anism, has been linked to LaminB1 degradation through
direct interaction with LC3 as a mechanism of protection
from oncogenesis and of reinforcement toward cellular
senescence [8]. However, the importance of nucleophagy
and its relationship with neuronal degeneration has not
been established.
Polyglutamine (polyQ) diseases are neurological condi-
tions due to an expanded CAG repeat resulting in polyQ
stretches in the encoded protein. This family of disorders
includes Huntington’s disease, dentatorubral-pallidoluysian
atrophy (DRPLA), and several spinocerebellar ataxias. DRPLA
is caused by the expansion of a CAG stretch in the
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ATROPHIN-1 (ATN1) gene [9]. Patients display ataxic and
choreoathetoid symptoms as well as myoclonus, generalized
epilepsy, and dementia with extensive cellular degeneration
found in the basal ganglia (e.g., the globus pallidus, GP), brain-
stem (e.g., the red nucleus, RN), and cerebellum (primarily in
the dentate nucleus, DN) [10].
Several DRPLA mouse models have been previously gener-
ated, all recapitulating important aspects of the disease
[11–13]. We have predicted dysfunctional autophagy from
previous Drosophila studies on DRPLA [14, 15]. Here, we
show that progressive development of an ataxic phenotype
in DRPLA mice is linked to severe cellular pathology in
relevant neuroanatomical regions. We reveal that neurode-
generation is associated with a stall in canonical autophagy
and the activation of alternative pathways of Golgi-dependent
and nucleophagy-based degradation and excretion of
LaminB1, leading to disruption of nuclear integrity and to
cell atrophy.
RESULTS
Progression of Motor Behavior Defects in DRPLA Mice
The behavioral phenotypes of ATN1-FL-26Q-84 (ATN1-FL-26Q)
and ATN1-FL-65Q-105 (ATN1-FL-65Q) mouse lines were evalu-
ated in greater detail than previously reported. Compared to
both wild-type (WT) mice and the ATN1-FL-26Q-84 (ATN1-FL-
26Q) line, the ATN1-FL-65Q-105 (ATN1-FL-65Q) line showed
clear decline in the rotarod (Figures S1A and S1B) and grip
strength tests (Figures 1A–1D). This was also reflected in the
earlier onset of jerky movements, tremors, hind limb clasping,
seizures, and a stronger progressive lack of weight gain (Figures
S1C and S1D; Movie S1).
Furthermore, the ATN1-FL-26Q and ATN1-FL-65Q lines
seemed to be hyperactive compared to WT. ATN1-FL-26Q
mice showed increased explorative behavior (Figure S1E;
Movie S2), while the ATN1-FL-65Q mice appeared rather
aggressive and anxious, as reflected in increased thigmo-
taxis (Figure 1E) [16]. The ATN1-FL-26Q line also showed a
significant increase in general activity as compared to WT
mice (Figures 1F and S1F). ATN1-FL-65Q, but not ATN1-
FL-26Q, displayed a severely altered, distinctively ataxic
gait (Figure 1G).
Stall in Autophagy in DRPLA
Previous Drosophila studies indicated a blockage of autophagic
clearance in DRPLA [14].
Lipofuscin accumulates during aging and also in lysosomal
storage disorders with dysfunctional autophagy [17]. We found
a significant accumulation of lipofuscin in DRPLAmouse models
in several brain regions (Figures 2A–2C, S2A, and S2B).
This was confirmed in transmission electron microscopy
(TEM) micrographs from DN cells (Figures 2D–2F) showing elec-
tron-dense tertiary lysosomes, characterized as lipofuscin,
especially in the ATN1-FL-65Q mice (Figures 2F and 2G).
Furthermore, in ATN1-FL-65Q we observed accumulations of
multilamellar bodies (Figure 2I), and of double-membrane auto-
phagic vesicles, often containing partially preserved debris (Fig-
ures 2J–2L), suggesting incomplete digestion.
The autophagy flux was evaluated in vivo using GFP-LC3
transgenic mice [18]. DN cells in ATN1-FL-65Q mice showed a
significant increase in GFP-LC3 puncta, as early as 3 weeks of
age, with further increase observed in end-stage animals (Fig-
ures 2M and 2N). Similar effects were observed in the RN in
the brainstem (Figure S2E), but not in the GP (Figure S2F) and
in any other forebrain region (Figure S2E). The ATN1-FL-26Q
line showed an initial increase of GFP-LC3 puncta in the DN at
3 weeks but not at end-stage (Figures 2M and 2N) in any of the
brain areas analyzed (Figures S2E and S2F).
The number of LAMP2A positive lysosomes did not differ
across genotypes (Figure S2C); however, the number of GFP-
LC3/LAMP2A double-positive autolysosomes was increased in
ATN1-FL-65Q (and partially in ATN1-FL-26Q) DNcells at 3weeks
(Figure S2D). At end-stage, normalizing the GFP-LC3/LAMP2A
double-positive puncta, over the total of GFP-LC3 puncta (re-
flecting the ratio of autolysosomes over the total of autophagic
vesicles) the number of autolysosomes had actually decreased
in the ATN1-FL-65Q and ATN1-FL-26Q lines (Figure 2O). This
contrasts with the initial increase at 3 weeks of age in the
ATN1-FL-65Q, suggesting a change in the status of autophagy
with pathology progression.
We also biochemically analyzed autophagy on a global scale.
The extraction process separated a liquid supernatant from a
pellet fraction. No changes were detected at 3 weeks of age
for GFP-LC3 and p62 in any brain area (Figure S3A). Thus, the
mild autophagic flux alterations observed at this stage are limited
Figure 1. Behavioral Assessment of DRPLA Mice
(A–D) Grip strength analysis revealed the progression of degenerative decline in ATN1-FL-65Qmice (red) compared to wild-type mice (WT, black) and ATN1-FL-
26Q (blue) over time asmeasured by repeated-measures two-way ANOVA. This was evidenced by significant interaction between age (v1) and genotype (v2) (Xp <
0.05,XXp < 0.01, XXXp < 0.001) when measuring both limbs (A and B). Hereby the progression was stronger in males signified by stronger interaction in both limbs
(B) compared to females (A). In addition, males showed progression when only forelimb grip strength was measured (D). In contrast, females showed overall
decreased non-progressive grip strength levels for fore limbs (C). Individual values are given as mean ± SEM and significance levels for individual time points are
assigned above with *p < 0.05, **p < 0.01, and ***p < 0.001.
(E) Thigmotaxis as ameasure of anxiety was evaluated for the first 5min after introduction to the open field by assessing the time 10-week-old males and females
spent in the outer zone. The ATN1-FL-65Q (65Q, red) line showed a significantly higher tendency to remain close to thewalls of the arena as compared to thewild-
type (wt; black) and ATN1-FL-26Q (26Q; blue) mice. Automatic quantification using EthoVision 7XT software. One-way ANOVA, **p < 0.01.
(F) General activity was assessed in females at 10 and 14 weeks evaluating the distance traveled from 5 to 25 min after introduction to the open field. ATN1-FL-
26Q (blue) mice were significantly more active compared to the wild-type (WT; black) at 10 weeks. This difference was more pronounced at 14 weeks of age with
both the ATN1-FL-26Q and ATN1-FL-65Q (red) lines being more active than the wild-type, while ATN1-FL-65Q mice were less active than ATN1-FL-26Q. An
interaction with age was not observed (repeated-measures two-way ANOVA, v1, genotype; v2, age). Automatic quantification using EthoVision 7XT software.
One-way ANOVA *p < 0.05, **p < 0.01, and ***p < 0.001.
(G) In gait analysis at 18 weeks of age, ATN1-FL-26Q shows a typical coordinated and regular footprint placing the hind paws (red) close to front paws (blue). In
contrast, ATN1-FL-65Q shows an uncoordinated pattern typical for ataxia.
See also Figure S1.
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to the DN of DRPLA mice. However, pronounced global defects
become apparent at the symptomatic stage. In the 14 weeks
cerebellum, there was a significant downregulation of the
Atg5-12 conjugate formation and of the GFP-LC3-II/-I ratio (Fig-
ures 3A–3C), as well as of GFP-LC3-II (Figures S3C and S3D) in
ATN1-FL-65Q in the supernatant fraction, which was accompa-
nied by a significant increase in the cleaved GFP/GFP-LC3 ratio
and of the levels of p62 in the pellet (Figures 3D–3F). These
changes were also maintained at end-stage (Figure 3G).
A similar, albeit somewhat delayed, effect to that in the cere-
bellum was visible in the brainstem lysates of the ATN1-FL-
65Q line (Figures S3E–S3K). The ATN1-FL-26Q line appeared
comparable to WT, except for a decrease in the cleaved GFP/
GFP-LC3 ratio at 14 weeks of age (Figures S3I and S3J). Finally,
no autophagy alteration was detected in the forebrain at any time
point (Figure S3L).
Despite robust similarities indicating block at lysosomal level
as observed in Drosophila DRPLA models, in DRPLA mice we
detected additional events that indicate the presence of feed-
back inhibition on autophagy signaling.
The alterations in the cerebellum at the symptomatic stage
of 14 weeks are consistent with a block in autophagic clear-
ance, combined with a reduction in signaling required for the
formation of new autophagosomes, perhaps result of a feed-
back loop. In agreement with this, we detected a reduction
in phosphorylation of Atg13 on S318 (Figure S4A) and a signif-
icant decrease in mRNA and protein levels of Tfeb (Figures
3H–3J), the master regulator of the autophagosome-lysosome
system [19]. The feedback loop did not appear to be mediated
by activation of mTOR, which displayed rather a trend toward
inactivation, as shown by phosphorylation of p70S6 kinase
(Figure S4A). The repression of Tfeb in ATN1-FL-65Q mice is
also indicated by absence from the nucleus of DN neurons
(Figure S4B), and decreased transcription of at least two of
its target genes (Figure 3K). The ATN1-FL-26Q line showed
almost no difference from WT with the exception of a mild
reduction in the GFP-LC3-II/-I ratio (Figures 3A and 3B) and
GFP-LC3-II (Figures S3I and S3J) at 14 weeks in the cere-
bellum, as well as a tendency to reduction in mTOR signaling
(Figure S4A).
To validate whether the stall in autophagy signaling in DRPLA
is present also in human cells, we used fibroblast lines from two
DRPLA patients. The human fibroblasts failed to respond to
acute 6-hr treatment with the autophagy inducer Rapamycin
(Rap) or with the autophagy clearance blocker Bafilomycin A1
(BafA1), whereas a control fibroblast line displayed the typical
increase in LC3I to LC3II conversion, upon Rap treatment, as
well as increased accumulation of LC3II, upon treatment with
BafA1 (Figure 3L). Chronic 24-hr treatment with BafA1 elicited
a modest but reproducible response from the DRPLA human fi-
broblasts, including significant reduction in LC3I/II conversion
and accumulation of p62 (Figures S4C–S4G), suggesting a
block in autophagosomal biogenesis. We further confirmed
the block in autophagosome formation in DRPLA cells
with the tandem reporter RFP-GFP-LC3B (Figures 3M and
3N). The ratio between RFP+ and RFP+/GFP+ positive puncta
in DRPLA cells did not increase with starvation and was also
not affected by additional treatment with BafA1, suggesting
also impaired progression and clearance of the few autophago-
somes present (Figure S4H). Thus, patients’ cells display the
same phenotype detected at late stages in the progression of
cellular pathology in DRPLA mice, i.e., canonical autophagy
signaling, the formation of new autophagosomes, and their
clearance are stalled.
Figure 2. Accumulation of Undigested Autophagic Structures in Cells of the Dentate Nucleus at End-Stage in DRPLA Mice
(A–C) Increased accumulation of lipofuscin-like autofluorescence in the dentate nucleus of ATN1-FL-65Q (C) and a lower level of increase in ATN1-FL-26Q (B)
mice compared to wild-type (A). Confocal laser scanning microscope image lex = 514 and 633. Scale bar, 10 mm. For quantification, see Figure S1G; for ex-
amples of autofluorescence bleaching, see Figure S2A.
(D–F) Low-magnification TEM images of DN cells show an accumulation of tertiary lysosomes as electron dense vesicular structures with transparent lipid in-
clusions, known as lipofuscin (red arrowheads) in ATN1-FL-65Q mice (F) compared to wild-type (WT, D) and ATN1-FL-26Q (E). nuc, nucleus; mt, mitochondria;
ER, endoplasmatic reticulum; mb, plasma membrane. Scale bar, 1 mm. Higher-magnification image of (F) is shown in Figure 5B.
(G and H) High-magnification TEM images of tertiary (late) lysosomes resemble the typical structure of lipofuscin-packed electron dense lamellar matrix con-
taining intravesicular lipid inclusion as an electron transparent circular structure. (G) ATN1-FL-65Q and (H) wild-type (WT). mt, mitochondria. Scale bar, 500 nm.
(I) High-magnification TEM image shows dense accumulation surrounded by multiple membranes (black arrowhead) as observed in ATN1-FL-65Q dentate
nucleus cells, often referred to as a multilamellar body. Scale bar, 500 nm
(J) Example of a cell showing multiple accumulations of tertiary lysosomes (red arrowheads) and double-membrane autophagic vesicles (black arrowheads)
containing undigested debris frequently observed in ATN1-FL-65Q dentate nucleus cells. Scale bar, 1 mm. Lower-magnification representation of the nucleus is
shown in Figure 5A.
(K) Magnification of the inset in (J) showing two double-membrane vesicular structures (black arrowheads), containing undigested material. Scale bar, 500 nm.
(L) High-magnification image of an autophagosome (arrow), as a double-membrane vesicular structure containing several endosomes (full arrowhead), and an
undigested former mitochondrion (framed arrowhead). Scale bar, 500 nm.
(M) Representative images of dentate nucleus cells fromWT;GFP-LC3, ATN1-FL-26Q;GFP-LC3, and ATN1-FL-65Q;GFP-LC3 end-stagemice evaluated for GFP
(green) and LAMP2a (red) positive as well as colocalized (yellow) puncta. Puncta were counted within the soma of cells, showing typical morphology for DN
neurons with large low-intensity nuclei (blue) surrounded by a relatively large cytoplasm and a high LAMP2a positive background. Images were taken at
the nuclear level of the cell with Axiovert epifluorescence microscope using Apotome optical sectioning with high grid at 1003 objective magnification. Scale
bar, 10 mm.
(N) Quantification of GFP-positive puncta in dentate nucleus cells ofWT;GFP-LC3 (wt), ATN1-FL-26Q;GFP-LC3 (26Q), and ATN1-FL-65Q;GFP-LC3 (65Q)mice at
the presymptomatic stage of 3 weeks (wt, n = 83 cells, 3 animals; 26Q, n = 77 cells, 3 animals; 65Q, n = 96 cells, 4 animals) and end-stage (wt, n = 53 cells,
3 animals; 26Q, n = 49 cells, 3 animals; 65Q, n = 52 cells, 3 animals). One-way ANOVA, mean ± SEM, ***p < 0.001, **p < 0.01.
(O) Relative co-localization ratio of puncta positive for both GFP-LC3 and LAMP2a to puncta positive for only GFP-LC3 in dentate nucleus cells of 3week and end-
stage WT;GFP-LC3 (wt), ATN1-FL-26Q;GFP-LC3 (26Q) and ATN1-FL-65Q;GFP-LC3 (65Q) mice. One-way ANOVA, mean ± SEM, **p < 0.01, *p < 0.05.
See also Figure S2.
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Nuclear Degeneration through Nucleophagy-Based
Cytoplasmic Displacement of LaminB1 following Block
in Canonical Autophagy
In parallel with autophagy stalling, we detected prominent nu-
clear pathology in DRPLAmice. In DN neurons, there was a strik-
ing accumulation of p62 inside the nucleus of the ATN1-FL-65Q
mice with the formation of a large inclusion (Figure 6Aiii), which
appeared to be composed of smaller aggregates at end-stage
(Figure S5A). The abnormal nuclear accumulation of p62 sug-
gests a specific pathological defect in the nucleus. TEM analysis
of DN neurons revealed that at end-stage these cells have a strik-
ingly deformed nucleus (Figure 4A; see also Figure 6Ai), with
parts bulging out, especially those rich in heterochromatin, and
with the appearance of vacuolar-like structures at the periphery.
Reviewing previous TEM data, we noticed that nuclear deforma-
tion was also present in Drosophila DRPLA models and fat mu-
tants [14, 15]. Indeed, also in the Drosophila central brain, the
normal circular organization of LaminB in the cortex of neuronal
nuclei is significantly altered and irregular in aged DRPLA flies,
with some cells showing ruffles and gaps (Figures 4B and 4C).
Most interestingly, human control fibroblasts lose the normal
LaminB1 organization and display inward ruffles of the lamin
layer when treated with BafA1 for 48 hr (Figure 4D). DRPLA fibro-
blasts also display LaminB1 inward ruffles when treated with
BafA1 and, remarkably, alsowhen treatedwith Rap for 48 hr (Fig-
ure 4D). In addition, whereas both control and DRPLA cells
reduce their nuclear size when treated with Rap and BafA1 (Fig-
ure 4E), only control fibroblasts increase the roundness of their
nucleus, opposite to DRPLA fibroblasts (Figure 4F). This indi-
cates that human DRPLA cells respond differently than control
cells to Rap and BafA1 and that chronic blockage of the auto-
phagy-lysosome clearance by BafA1 makes control and patient
cells converge toward parameters characteristic of DRPLA
nuclei (Figure 4G).
Next, we have tested nuclear shape dynamics in fibroblasts
from Vici syndrome (VS) patients. VS is an early-onset infantile
multisystem disorder with well-characterized autolysosomal
blockage due to mutations in the EPG5 gene [20, 21], which is
required for the autophagosome-lysosome fusion [22]. VS fibro-
blasts displayed similar nuclear shape dynamics as the DRPLA
fibroblasts upon 48-hr BafA1 treatment (Figures S5B and S5C).
Interestingly, the age-matched (3 years old) control cells were
hardly affected by this treatment, in contrast to the age-matched
(51 years old) DRPLA controls, probably reflecting different
resistance and plasticity, due to the age difference.
Furthermore, in human neuroblastoma cells SK-N-BE(2) trans-
fected with mCherry-LaminB1, genetic block of autophagy by
Atg6 small interfering RNA (siRNA) decreased the roundness of
the nucleus (Figures S5D and S5E). A similar trendwas displayed
after Atg5 knockdown.
We therefore reasoned that defects in nuclear shape dy-
namics may be linked to the recently reported role of autophagy
Figure 3. Inhibition of Autophagy Flux at Lysosomal Level and Decrease in Autophagy Initiation Signaling in DRPLA
(A–C) The ratio of LC3II to LC3I was used to quantify autophagic flux in western blot analysis of full-length GFP-LC3 in the supernatant fraction of cerebellar
lysates at 14 weeks of age (A). The anti-LC3 antibody recognizes a doublet between 35 and 55 kDa (Figure S4B), consistent with GFP-LC3-I (upper) and cleaved
GFP-LC3-II (lower). The level of Atg5-12 conjugate was used to quantify the events of autophagy initiation. Densitometric analysis shows a decreased relative
abundance of cleaved GFP-LC3-II to full-length GFP-LC3-I (B) in ATN1-FL-65Q;GFP-LC3 (65Q) mice compared to ATN1-FL-26Q;GFP-LC3 (26Q) and WT;GFP-
LC3 (wt) mice. Atg5-12 conjugate (C) is also decreased in ATN1-FL-65Q;GFP-LC3 (65Q) compared toWT;GFP-LC3 (wt). Student’s t test, mean ± SEM, **p < 0.01,
*p < 0.05.
(D–F) The accumulation of GFP cleavage product and autophagy receptor p62was analyzed as ameasure of autophagy flux blockage inwestern blot assay of the
cerebellar lysates at 14 weeks of age (D). Mouse anti-GFP antibody recognizes only GFP-LC3-II (Figure S4B) and cleaved GFP after longer exposure. *Shorter
exposure of anti-GFP signal. Densitometric analysis of the relative abundance of cleaved GFP to GFP-LC3-II (E) as well as the abundance of p62 relative to
a-tubulin (F) in WT;GFP-LC3 mice (wt), ATN1-FL-26Q;GFP-LC3 (26Q) and ATN1-FL-65Q;GFP-LC3 (65Q) mice. Student’s t test, mean ± SEM, *p < 0.05.
(G) Accordingly, western blot analysis of autophagy shows a stall in autophagy flux in end-stage ATN1-FL-65Qmice compared to wild-type (WT) as evidenced by
relative decrease of GFP-LC3-II as well as increase of p62 in the pellet fraction. *Anti-p62 antibody revealed an additional band 20 kDa above the expected band
at around 60 kDa in the supernatant fractions of the cerebellum in end-stage mice.
(H) qPCR analysis of TfebmRNA levels in the cerebellum of wild-type (wt, white), ATN1-FL-26Q (26Q, blue) and ATN1-FL-65Qmice (65Q, red) at presymptomatic
(3 weeks) and early symptomatic (10weeks) time points. Relative levels normalized to b-actin andHprt1 are given as a fold change of wild-type. Two-way ANOVA,
v1, genotype; v2, age, mean ± SEM (n = 6), ***p < 0.001.
(I and J) Levels of Tfeb protein in the supernatant fraction of cerebellar lysates at 14 weeks of age (I). Densitometric analysis (J) reveals a significant decrease in
ATN1-FL-65Q;GFP-LC3 (65Q) compared to WT;GFP-LC3 (wt). One-way ANOVA, mean ± SEM, **p < 0.05.
(K) qPCR analysis of Ctsb and Prkag mRNA levels in the cerebellum of wild-type (wt, white), ATN1-FL-26Q (26Q, blue) and ATN1-FL-65Q mice (65Q, red) at an
early symptomatic (10 weeks) time point. Relative levels normalized to Hprt1 are given as a fold change of wild-type. One-way ANOVA, mean ± SEM (n = 6), *p <
0.05, **p < 0.01, ***p < 0.001.
(L) Whole-cell lysates of human fibroblasts from healthy control and DRPLA patients were subjected to western blot analysis for endogenous LC3-I and LC3-II as
well as p62. Induction of autophagy with Rap and block with BafA1 for 6 hr resulted in increase of LC3II compared to DMSO in control fibroblasts, while there was
no acute response observed in DRPLA patient samples. No changes in p62 levels were evident after 6 hr acute treatment.
(M and N) Analysis of the autophagy flux in control and DRPLA fibroblasts (DRPLA 17) transfected with the tandem RFP-GFP-LC3B reporter. Starvation in Hank’s
balanced salt solution (HBSS) mediumwas used to induce autophagy, BafA1 treatment to inhibit lysosomal degradation. Autophagosomes aremarked by yellow
signal as a result of combined RFP and GFP double fluorescence. Due to quenching of the GFP signal in acidic environment autolysosomes show RFP fluo-
rescence only. Representative images acquired with Nikon spinning disc confocal microscope display a greater amount of autophagosomes and autolysosomes
in control fibroblasts compared to DRPLA after starvation in HBSS for 3 hr (M). Quantification in (N) demonstrates a significant increase in both autophagosomes
and autolysosomes in control but not in DRPLA cells after starvation. Addition of BafA1 to starvation medium resulted in a greater number of GFP+RFP+ puncta as
compared to starvation only in control cells. No changes were significant in DRPLA patient fibroblasts (see also Figure S6H). Significance values in the columns
show differences for fed versus starved condition and starved versus +BafA1 condition for RFP+ or GFP+RFP+ puncta. One-way ANOVA, mean ± SEM, *p < 0.05,
***p < 0.001. Significance values between control and DRPLA cells for overall puncta are shown above the horizontal bars, two-way ANOVA ***p < 0.001; v1,
genotype; v2,- total GFP+ and GFP+RFP+ puncta. Scale bar, 20 mm.
See also Figures S3 and S4.
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in the degradation of nuclear lamina [8] and have analyzed
LaminB1 interaction with the autophagy machinery. In DN neu-
rons, LaminB1 is distributed in speckles of puncta throughout
the nucleus. In ATN1-FL-65Q mice, we detected a significant
accumulation of larger LaminB1 dots in the cytoplasm (Figures
5A and 5B), whichwas one of the earliest cellular phenotypes de-
tected at 3 weeks in these mice (Figures S7E and S7H). At end-
stage, many of the LaminB1 puncta co-localized with GFP-LC3
(Figures 5A, 5C, and S6A) in particular in the ATN1-FL-65Q line
(Figure 5C). While some of the brighter dots localize in close
proximity or co-localize directly with p62, also in WT and
ATN1-FL-26Q lines, the majority displayed a segregated distri-
bution (Figure S5A). In particular, many more puncta were de-
tected in ATN1-FL-65Q mice, but there was no overall overlap
with the intranuclear p62 inclusion (Figure S5A). In contrast,
many LaminB1 puncta co-localized with polyQ protein aggre-
gates, mostly inside the nucleus, but also in the cytoplasm in
DN neurons (Figure 5D) and Purkinje and granule cells (Fig-
ure S6B). Despite the reduced number of polyQ dots in WT
and ATN1-FL-26Q lines, some co-localization could be
observed also in these cases (Figures S6B and S6C). In granule
cells, ATN1-FL-65Q induced complete disorganization of nu-
clear LaminB1 at end-stage (Figure S6B), whereas at 3 weeks
only early signs of incomplete circular organization were detect-
able (Figure S6C). Interestingly, overexpression of ATN1-FL-26Q
at end-stage was sufficient to induce a disorganization of
LaminB1 in some cells (e.g., granule cells, Figure S6B), but not
in others (e.g., DN neurons).
Neuronal cell degeneration in theATN1-FL-65Qmicecorrelates
with the increased localization of LaminB1 into the cytoplasm
early on. This likely relates to the disruption of the nuclear shape
(Figure 5A), the severe alterations in DNA and chromatin appear-
ance (Figure S6E) and the increased levels of gH2AX (Figures S6F
and S6G), a marker of senescence and DNA damage [23].
We used human DRPLA fibroblasts for further functional anal-
ysis. Here, we also detected a significantly higher number of
Figure 4. Loss of Nuclear Integrity in Mouse
and Drosophila Models for DRPLA and in
DRPLA Patients’ Fibroblast
(A) TEM images of dentate nucleus cells in wild-
type (WT, top) and ATN1-FL-65Q (bottom) mice.
The latter is displaying irregular shaped nuclei,
where the electron dense structures (heterochro-
matin) are bulging out at the periphery (arrow) with
electron-lucent vacuolar-like structures (arrow-
heads). nuc, nucleus. Scale bar, 5 mm.
(B and C) Overexpression of Drosophila polyQ
Atrophin and LacZ as a control using the UAS-
Gal4 system specifically in adult glial and neuronal
cells driven by repo and elav promotors. The
expression was induced in fully developed adult
flies for 14 days by utilizing ubiquitously expressed
temperature sensitive Gal4 repressor UbiGal80TS
and inactivated at 29C. The confocal images
of Drosophila LaminB show irregular lamina (ar-
rowheads) in sAtro75QN overexpressing flies
compared to LacZ expressing flies (B), which is
reflected in significant loss of circularity (ImageJ,
particle analysis): mean ± SEM, n = 5, Student’s
t test ***p < 0.001 (C).
(D–G) Analysis of nuclear shape dynamics in
DRPLA (17) patient fibroblasts and age-matched
control after 48-hr treatment with Rap and BafA1.
Representative images show folding of nuclear
envelope revealed by the aLaminB1 antibody
upon treatment with BafA1 in both control and
DRPLA (arrows), while Rap induced folding
(arrowhead) in DRPLA fibroblasts (D). The struc-
tural changes were reflected by a decrease in
nuclear size after treatment in both control and
DRPLA cells (E). While the nuclear roundness
decreased in DRPLA cells, it increased in controls
(F). The plot of roundness versus area shows an
opposite trend and convergence of controls and
DRPLA nuclei upon BafA1 treatment (G). Auto-
mated quantification was performed using Opera
Phenix high-content screening system and Co-
lumbus software. Mean ± SEM, n = 5, two-way-
ANOVA ***p < 0.001, *p < 0.05; v1, genotype; v2,
treatment. Scale bar, 50 mm.
See also Figure S5.
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cytoplasmic LaminB1 puncta after 48 hr (Figures 5E and 5F).
Block of lysosomal clearance with BafA1 strikingly augmented
cytoplasmic LaminB1, overpowering any difference between
DRPLA and control fibroblasts. Longer culturing for 72 hr led to
an overall increase in cytoplasmic LaminB1 eliminating the
difference between control and DRPLA fibroblasts, potentially
masked by disappearance of more severely affected DRPLA
cells. However, 72-hr Rap treatment had an extraordinary effect
in DRPLA fibroblasts (not seen in control cells) on the accumula-
tion of cytoplasmic LaminB1 (Figures 5E and 5F). Interestingly,
BafA1 treatment had a progressive effect on cell death with con-
trol fibroblasts displaying a significant reduction in cell number
only after 72 hr (Figure 5F), whereas DRPLA fibroblasts displayed
a significant decrease in cell number already at 48 hr (Figure 5F)
probably due to exacerbation of an already present blockage in
the autophagy-lysosome clearance.
Overall, these data inmice and human cells suggest that a stall
in canonical autophagy triggers an accumulation of LaminB1 in
the cytoplasm, which correlates with nuclear degeneration in
DRPLA mice and cell death in human fibroblasts.
Degradation and Excretion of Cytoplasmic LaminB1
during Cell Degeneration
In Ras-induced cancer models, nucleophagy has been shown to
result in the lysosomal degradation of LaminB1 through auto-
phagy [8]. However, given the stall in autophagy in DRPLA or
Figure 5. Lamin-Based Nucleophagy Asso-
ciates with PolyQ Inclusions in DRPLA Mice
and Is Aggravated in Human DRPLA Fibro-
blasts upon Lysosomal Blockage
(A–C) Representative images of dentate nucleus
cells from WT;GFP-LC3 (WT, left), ATN1-FL-
26Q;GFP-LC3 (middle), and ATN1-FL-65Q;GFP-
LC3 (right) end-stage mice show co-localization
(yellow) of GFP-LC3 (green) and LaminB1 (red) in
the nucleus (framed arrowheads) and, in partic-
ular, in the cytoplasm (full arrowheads) of ATN1-
FL-65Q cells (A). The nucleus is visualized in blue.
Single-plane images were taken with the confocal
laser scanning microscope. Quantification in-
dicates a significant increase in the amount of
cytoplasmic LaminB1 (B) and of its co-localization
with GFP-LC3 (C) in ATN1-FL-65Q;GFP-LC3
mice compared to WT;GFP-LC3 and ATN1-FL-
26Q;GFP-LC3. One-way-ANOVA ***p < 0.001,
*p < 0.05. Scale bar, 5 mm.
(D) Some nuclei in ATN1-FL-65Q;GFP-LC3 show
strong degeneration reflected in LaminB1 reor-
ganization forming bright intranuclear puncta.
Intranuclear (framed arrowheads) and also cyto-
plasmic (full arrowheads) LaminB1 puncta coloc-
alize with PolyQ positive puncta. Scale bar, 5 mm.
(E and F) Analysis of LaminB1 redistribution into
the cytoplasm in DRPLA patient fibroblasts and
age-matched control after 48- and 72-hr treatment
with Rap and BafA1. Representative images
show cells after 72-hr treatment visualized with
a-LaminB1 antibody (E). Upon treatment with
BafA1 both control (white) and DRPLA (red) fibro-
blasts show an increase in LaminB1 positive
puncta after 48 and 72 hr, while Rap increased
cytoplasmic LaminB1 puncta only after 72 hr in
DRPLA fibroblasts (F). In line the effect inhibitory
effect of mTOR on proliferation, Rap resulted in
significant decrease of relative cell number (p <
0.001 not shown). BafA1 treatment for 48 hr re-
sulted in decreased cell number only in DRPLA
samples in contrast to controls, while after 72 hr
there was a significant reduction in cell number in
both control and DRPLA samples. Automated
quantification was performed using Opera Phenix
high-content screening system and Columbus
software. Mean ± SEM, two-way-ANOVA ***p <
0.001. Scale bar, 50 mm.
See also Figure S6.
3634 Current Biology 27, 3626–3642, December 4, 2017
(legend on next page)
Current Biology 27, 3626–3642, December 4, 2017 3635
following BafA1 treatment, we reasoned that alternative clear-
ance routes may be employed for the LaminB1 accumulated in
the cytoplasm.
TEM investigation of ATN1-FL-65Q DN cells also suggests
that alternative routes to canonical autophagy may be active in
DRPLA. Remarkable perinuclear membranous accumulation
(Figure 6A), which surrounded cytoplasmic components en-
riched with electron dense spots (Figure 6Aii). Similar structures
have been referred to as aggresomes [24], which are formed
close to the nucleus upon strong autophagy induction in
association with p62 and LC3. Indeed, some DN cells formed a
perinuclear p62- and GFP-LC3-positive structure (Figure 6Aiii).
A general disorganization of intracellular membranes in the
ATN1-FL-65Q cells was observed (Figures 2D–2F), also in the
distal cytoplasmic regions, where long phagophore-like struc-
tures were formed (Figure 6B). Given the abnormal membrane
organization, we reasoned that endoplasmatic reticulum (ER)
stress could have been induced, also known to induce auto-
phagy [25]. Bip and Chop are ER-stress-responsive genes that
are known to be regulated by all three pathways, Bip predomi-
nantly by the ATF6 pathway and Chop predominantly by the
PERK pathway. The splicing of the mRNA encoded by the
Xbp1 gene is selectively regulated by the IRE1 pathway. We
find a significant increase of Bip but not spliced Xbp1 and
Chop mRNAs in the ATN1-FL-65Q mouse line at pre-symptom-
atic stages (Figure S7A), but this is not sustained at early symp-
tomatic stages, with the proapoptotic Chop being significantly
downregulated (Figure S7B).
We then analyzed at end-stage the other major source of intra-
cellular membranes, the Golgi apparatus, reported to participate
in autophagy [26, 27] also as non-canonical Golgi membrane-
associated degradation (GOMED) in Atg5- and 7-deficient cells
[28, 29]. Relatively large double-membrane vesicular structures,
in some cases rather complex with vesicles apparently enclosed
in each other (Figure 6C) were evident in the ATN1-FL-65Q line.
In addition, theGolgi marker GM130 localized in enlarged tubular
structures in the ATN1-FL-65Q DN cells at end-stage, in close
proximity to GFP-LC3 puncta (Figure 6D). The whole GM130
compartment displayed an increase in size in end-stage ATN1-
FL-65Q DN cells compared to ATN1-FL-26Q and a similar trend
toward WT, with a significant shift in the cell distribution toward
larger Golgi size (Figures 6E and S7C). This phenotype was not
seen at an earlier stage (Figures S7E and S7F); however, the
Golgi was significantly, albeit only transiently, more fragmented
at 3 weeks in ATN1-FL-26Q and ATN1-FL-65Q mice (Figures
S7D, S7E, and S7G). Golgi fragmentation has been associated
with induction of non-canonical autophagy [30].
These data indicate an evolution of Golgi pathology from early
stages in DRPLA mice. To assess the mechanistic role of the
Golgi in the accumulation of cytoplasmic LaminB1, we treated
human DRPLA fibroblasts with Brefeldin A (BrefA), which com-
promises Golgi integrity and function [31]. BrefA treatment per
se induced dramatic LaminB1 cytoplasmic accumulation in
DRPLA fibroblasts, synergistic to the previously described
BafA1 effect (Figures 6F and 6G). Morphologically, in compari-
son to BafA1, BrefA induced the formation of larger LaminB1
puncta in a circular perinuclear pattern (Figure 6F), suggestive
of an organization around cellular organelles rather than diffused
cytoplasmic spreading. As in DRPLA, EPG5-deficient VS cells
displayed a significant increase in the accumulation of LaminB1
in the cytoplasmwith respect to controls in control conditions, as
well as under a number of treatments (Figures S7I and S7J).
Importantly, a synergic effect of BafA1 with BrefA was observed,
while no synergy was displayed between BafA1and Rap.
Overall, these data indicate that the Golgi is involved in the
degradation of cytoplasmic LaminB1, through a separate mech-
anism from that of canonical autophago-lysosomal digestion.
Many of these characteristics are shared by the recently
described GOMED pathway [29].
However, we find that not all LaminB1 that localizes to the
cytoplasm is degraded. In DRPLA fibroblasts, cells rich in cyto-
plasmic LaminB1 puncta excrete small bodies containing
LaminB1 and p62 (Figure 7A). SK-N-BE(2) human neuroblastoma
cells, co-transfected with constructs encoding cytoplasmic
EGFP and an mCherry-LaminB1 chimeric protein, display similar
significant increase in cytoplasmic LaminB1 upon BafA1 treat-
ment (Figures S7K and S7L). In these cells, we were able to visu-
alize LaminB1 exit from the nucleus, trafficking to the cell surface
Figure 6. Aggresome-like Formation andGolgi-Mediated Degradation as Signs of Alternative Autophagy Induction in the Dentate Nucleus of
DRPLA Mice
(A) (i) TEM image of a dentate nucleus cell in ATN1-FL-65Q mouse containing a membranous aggresome-like (Agg) accumulation in close proximity to the cell
nucleus (nuc). Scale bar, 5 mm. (ii) Higher magnification of the inset in (i) containing the aggresome-like (Agg) membranous formation. Scale bar, 500 nm. ly,
lysosome; mt, mitochondrion. (iii and iii’) confocal fluorescence image of DN cell in ATN1-FL-65Q;GFP-LC3 mouse brain with p62 positive (red) inclusion inside
the nucleus (blue) as well as outside of the nucleus (arrowhead), which also co-localizes with GFP-LC3 (green).
(B) (i) TEM image of a dentate nucleus cell in ATN1-FL-65Q mice; in addition to a large perinuclear aggresome-like (Agg) structure, long membranous formations
(arrowhead) with phagophore-like structure are shown at the distal side of the cell soma. Scale bar, 2 mm (note this is a higher-magnification cutout of the image in
Figure 2F). (ii) High-magnification TEM image of a similar phagophore-like structure. Scale bar, 300 nm.
(C) Representative TEM images of dentate nucleus cells show double-membrane vesicular structures (arrowheads) in close proximity to the Golgi apparatus
(arrow) in ATN1-FL-65Q mice (right), compared to normal Golgi morphology in ATN1-FL-26Q (middle) and wild-type (WT, left) mice. Scale bar, 500 nm
(D and E) Confocal fluorescence microscopy images of dentate nucleus cells showing an enlarged Golgi apparatus (GM130, red) in ATN1-FL-65Q;GFP-LC3
mouse line (left) compared to ATN1-FL-26Q;GFP-LC3 line (middle) and WT;GFP-LC3 (WT, right) (D). Inset in the bottom row shows a higher magnification of a
GFP-LC3 (green) positive puncta in close proximity to GM-130 positive structures. Scale bar, 5 mm. Quantification of GM130 signal evidences an increase in the
ATN1-FL-65Q;GFP-LC3 mouse line (E). Kruskal-Wallis multiple comparison analysis, mean ± SEM, ***p < 0.001
(F and G) Analysis of LaminB1 redistribution into the cytoplasm in DRPLA (17) patient fibroblasts after 48-hr treatment with BafA1 and/or BrefA. BrefA was only
added for the last 24 hr. BafA1 and BrefA display an increased localization of LaminB1 into the cytoplasm showing different distribution patterns: diffused after
BafA1 treatment only and concentrated in large perinuclear puncta after BrefA treatment. Combined BafA1 and BrefA treatment shows synergistic effect on
cytoplasmic LaminB1 localization. Scale bar, 50 mm (F). Automated quantification of area occupied by LaminB1 positive puncta in the cytoplasm was performed
using Opera Phenix high-content screening system and Columbus software. Mean ± SEM, two-way ANOVA ***p < 0.001, **p < 0.01, *p < 0.05.
See also Figure S7.
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Figure 7. Excretion of LaminB1-Rich Buds following Autophagy and Golgi Impairment
(A) Representative image showing DRPLA (17) fibroblasts after 72 hr Rap treatment showing formation of buds at the plasmamembrane containing LaminB1 and
p62 puncta. High magnification of insets in the image is shown on the left. Scale bar, 25 mm.
(legend continued on next page)
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and expulsion from the cytoplasm (Figure 7B; Movie S3). In this
slow excretion process, the LaminB1-containing buds appear
to remain in close proximity of the cell for prolonged time after
expulsion from the cytoplasm, suggesting a link may be retained
(Movie S3). Most interestingly, co-transfection of siRNA against
key autophagy genes Atg5 and Atg6 increases the excretion of
LaminB1 in these cells (Figure 7C). We subsequently analyzed
the culture medium of DRPLA fibroblasts, using ultracentrifuga-
tion to further characterize the excretion products. LaminB1 in
the medium (and in the cytoplasm) appears as a fragment (Fig-
ure 7D), possibly resulting from proteolysis of the full-length
LaminB1 upon exit from the nucleus. The excreted LaminB1 frag-
ment also specifically accumulates in the 100,000 3 g fraction
upon ultracentrifugation (Figure S7M), which is known to be en-
riched inmicrovescicles and exosomes but not apoptotic bodies.
Treatment with BafA1 and BrefA, which significantly increases
the amount of LaminB1 in the cytoplasm (Figures 7D and 7E),
also facilitates a dramatic increase in LaminB1 and p62 in the
culture medium (Figures 7D–7G). BrefA treatment, in combina-
tion with BafA1, did not impair significantly the excretion of
LaminB1 or p62 (Figure 7F).
Taken together, these data indicate that autophagy inhibition
and Golgi impairment increase the amount of LaminB1 and
p62 excreted in buds, which share many characteristics of
microvesicles.
In neuroblastoma cells in culture, mCherry-LaminB1 puncta
can be found inside neighboring non-transfected cells, where
they often localize in the perinuclear areas (Figure 7H), reminis-
cent of the p62 rich aggresome-like structures observed in
DRPLA mice (Figure 6A). Thus, adjacent cells might mask the
shedding in the complexity of an in vivo model.
In conclusion, our data indicate that LaminB1 and associated
proteins are exported from the nucleus and then excreted
through a mechanism likely to underlie nuclear and cellular atro-
phy and death upon chronic autophagy inhibition.
DISCUSSION
The final stages of cell dysfunction and death in neurodegenera-
tive diseases and the atrophy of brain tissue remain elusive in
most cases. Recently, the nucleus has received much attention
as the organelle whose functionality is severely compromised in
aggregation-prone neurodegenerative diseases [1, 2]. Mutation
in genes encoding nuclear lamina constituents cause Hutchin-
son-Gilford progeria [32, 33], an accelerated aging syndrome
and have been associated with autophagic degradation of nu-
clear components [5].
The failure of autophagy in neurodegenerative diseases has
been extensively studied and proved to be of paramount impor-
tance inmost cases [6]. Our laboratory has previously developed
DRPLADrosophilamodels, in which we have reported defects in
autophagic clearance [14] and transcription of the fat cadherin
[15]. We have confirmed these defects in DRPLA mice, including
transcription of all mouse Fat genes (data not shown). Here, we
show accumulation of undigested autophagosomes and autoly-
sosomes (visualized by TEM), aswell as lipofuscin, p62, andGFP
cleavage product in the ATN1-FL-65Q mice, indicating insuffi-
cient autophagic clearance. Progressive accumulation of p62
in the nucleus acted as a faithful biomarker of cell pathology in
the different brain areas (data not shown). However, differently
than in Drosophila, at the behavioral level we observed gender
dimorphism in DRPLA mice, with males being affected more
strongly. Furthermore, we provide evidence of a significant effect
in terms of activity and exploration due to overexpression of a
WT form of human ATN1, a possible gain of function effect,
which is absent in the 65Q version and in Drosophila models.
This highlights the importance of the ATN1-FL-26Q line as an
additional control in our analysis, which is in accordance with
previous transcriptional analysis reporting 19% of gene expres-
sion changes in the ATN1-FL-26Q to be in common with the
ATN1-FL-65Q mice but not with a mouse models for Hunting-
ton’s disease [34]. Unsurprisingly, we observe several mild phe-
notypes in ATN1-FL-26Q mice, reflected in increased GFP-LC3
turnover in absence of p62 accumulation and in the reorganiza-
tion of LaminB1 in the cerebellar cortex. Significant differences
between the two ATN1 lines, such as increased accumulation
of lipofuscin, of LC3 puncta at end-stage and cleaved GFP in
combination with decreased Tfeb expression and that of two
of its targets, however, demonstrate that the stall in canonical
autophagy flux are solely attributed to the polyQ expansion in
the ATN1. Golgi enlargement at end-stage, increase in the
senescencemarker gH2AX, nuclear shape alterations, and cyto-
plasmic LC3-associated accumulation of LaminB1 are all spe-
cific signs of alternative autophagy induction and subsequent
(B) Still frames (taken formMovie S3) of confocal live imaging of a SK-N-BE(3) neuroblastoma cell expressing EGFP andmCherry-LaminB1 treated with BafA1 for
48 hr. Arrow points at a LaminB1 punctum detaching from the nucleus and getting slowly excreted over time. Note themisshapen nucleus and LaminB1 infolding.
Scale bar, 5 mm.
(C) Analysis of extracellular LaminB1 in SK-N-BE(2) neuroblastoma cells co-expressing EGFP and mCherry-LaminB1 as well as siRNAs against ATG5 or ATG6,
genes participating in autophagy and ATG-dependent secretion. Extracellular LaminB1-mCherry puncta were enriched in the surrounding region to EGFP
positive cells void of EGFP signal. Automated quantification of mCherry signal intensity was performed using Opera Phenix high-content screening system and
Columbus software. Mean ± SEM, one-way-ANOVA *p < 0.05.
(D–G) Analysis of excretion of cellular component in the medium of human DRPLA (17) fibroblasts treated with BafA1 and BrefA as in Figure 6F. The medium
supernatant was collected and subjected to ultracentrifugation, while the cells were lysed separating nuclear and cytoplasmic fractions. BafA1 and combined
BafA1/BrefA treatment increase the amount of LaminB1 in the cytoplasmic fraction (D and E). BafA1 increased significantly the amount of LaminB1 (D and F) and
p62 (D and G) in the medium supernatant fraction collected after 100,000 3 g ultracentrifugation; addition of BrefA did not significantly reduce the amount of
LaminB1 or p62 found in this fraction. Note that the LaminB1 band in cytoplasmic and medium supernatant fraction runs at a lower molecular weight of45 kDa
as opposed to the expected 70 kDa in the nuclear fraction, compatible with proteolytic cleavage. Densitometry of medium supernatant fractions was stan-
dardized over cytoplasmic tubulin representing the amount of cells and cytoplasm present in the culture. One sample t test, mean ± SEM, **p < 0.01, *p < 0.05.
(H) Representative image of SK-N-BE(2) neuroblastoma cells expressing EGFP, mCherry-LaminB1, and Atg6 siRNA shows the uptake of LaminB1 puncta by
neighboring cells. Arrow points at mCherry-LaminB1 dots found inside non-transfected cells. Phalloidin is used to mark the cytoplasmic area of all cells. Scale
bar, 10 mm.
See also Figure S7.
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nuclear degeneration in ATN1-FL-65Q animals, absent in ATN1-
FL-26Q controls.
The analysis of mouse models and human DRPLA cells has
additionally revealed that decreased autophagic degradation is
accompanied by alterations in canonical autophagy signaling,
which suggests a stall in the formation of new autophagosomes,
perhaps resulting from a negative feedback loop. Whereas mTor
activity displays a tendency toward inhibition, and thus auto-
phagy induction, the phosphorylation of Atg13 by ULK1, the for-
mation of Atg5-12 conjugates, and the rate of LC3-I/II conversion
are all downregulated. This is further compounded by downregu-
lation of Tfeb and at least two of its direct targets. Interestingly,
human TFEB has been shown to be involved in auto-regulatory
feedback loops in starvation-induced autophagy [35]. Human
DRPLA fibroblasts also failed to induce formation andmaturation
of autophagosomes following autophagy modulating treatment,
consistently with the recently reported defects in Beclin-1-
dependent autophagy induction [36].
In mice, however, the autophagy stall takes place after an
initial mild increase in autophagosomes and autolysosomes,
possibly driven also by the early moderate ER-stress and Golgi
fragmentation. Altogether, our current findings in mice support
a model in which neuronal cells challenged by polyQ ATN1
show an overall attempt to induce autophagy but, later on,
shut down canonical autophagy signaling, possibly as a result
of the inability to progress toward clearance. This suggests
that new autophagosomes are not formed through canonical
signaling at end-stage, and that the significant accumulation of
GFP-LC3 puncta in post-mitotic neurons in vivo rather results
from lack of digestion and/or alternative routes, including nucle-
ophagy. Human DRPLA fibroblasts in vitro do not display the
same accumulation of LC3 puncta, presumably because of cell
division and of the reduced time window for cell-culture
observations.
Recently, alternative autophagy routes, involving some varia-
tion of the canonical autophagy steps and signaling, have been
discovered, but their role in neurodegenerative diseases has
not been described yet.
Here, we detected alternative clearance pathways in DRPLA
mice. At end-stage, we observed formation of aggresome-like
structures and Golgi enlargement, both cellular correlates for
pathological induction of alternative autophagy routes. The
aggresomes have been proposed as a cellular pathway for
degradation of polyQ [37] and other aggregation-prone proteins
that escape canonical autophagy [38]. However, since DN neu-
rons lack a proper microtubule organizing center (data not
shown), it is unclear whether these structures alsomeet the func-
tional definition of aggresomes. TheGolgi apparatus, and its traf-
ficking with the ER, is disrupted in several examples of neurode-
generation. However, ER-stressmarkers, in particular, Chop, are
downregulated at later stages in DRPLA, perhaps in an attempt
to protect cells from apoptotic responses [39] or as a conse-
quence of lost membrane integrity, incompatible with any further
ER-stress induction. Conversely, we provide here the first in vivo
evidence for GOMED in an autophagy-challenged neuropa-
thology. The Golgi has been reported in vitro to engage specif-
ically with autophagy in certain contexts [27, 40], to be a possible
source for autophagic membranes in yeast [26] and mammals
[41], and to localize in close proximity to phagophores [42].
The involvement of the Golgi in autophagy is, thus, another
indication for extreme autophagy stress in the cerebellar nuclei
of DRPLA mice. The downregulation of GFP-LC3II conversion
and formation of Golgi-associated autophagic structures in
DRPLA mice strikingly resemble the alternative autophagy
routes described in Atg5- and Atg7-defective cells and mice
[28, 29], consistent with a block in canonical autophagy also in
DRPLA models.
We thus propose that, upon stalling of the canonical auto-
phagy machinery, cells attempt to maintain homeostasis via
alternative routes like GOMED-like degradation and excretion.
This, however, leads to irreversible damage, nuclear breakdown,
and to terminal cell atrophy and degeneration.
Here, we report the first in vivo evidence of a nucleophagy-
basedmechanism in neurodegeneration, reflected in the associ-
ation of nuclear LaminB1 with GFP-LC3 in the nucleus and in the
cytoplasm, the cytoplasmic accumulation of LaminB1, its degra-
dation and excretion. This process may be responsible for the
collapse of normal nuclear structure, which correlates with the
progressive accumulation of p62 in the nucleus and the increase
in DNA damage and senescence. Because of the lack of sub-
stantial co-localization of the LaminB1 puncta with p62, we inter-
pret the p62 accumulation in the nucleus, as a separate event,
which occurs either in parallel or as a consequence of the loss
of nuclear integrity, and constitutes a reliable biomarker for
cellular pathology (unpublished data). TEM pictures revealed
irregular nuclear shapes and morphological changes of nuclear
membrane, which may be indications for instability of, and
leakage from, the nuclear envelope. This was further backed
by the alteration of LaminB structure in both fly and mouse
models for DRPLA and in human fibroblasts from DRPLA and
VS patients, as well as in human neuroblastoma cells with in-
hibited autophagy. The export to the cytoplasm of nuclear
LaminB1 is likely to underlie the severe defects in nuclear shape,
causing disruption of nuclear integrity, which can be sensibly
connected to large-scale transcriptional aberrations, nucleo-
cytoplasmic transport, and terminal cell degeneration, all key
features of human neurodegeneration.
We speculate that in normal cells a low degree of nucleophagy
and of LaminB1 excretion might be an attempt at maintaining
nuclear health by rejuvenating nuclear lamina and perhaps
disposing of other nuclear proteins through autophagy and
excretion. In DRPLA, this may be an attempt to counteract the
effect of polyQ ATN1. This protein has been reported to interact
with nuclear matrix components at discrete locations [43], and
we observe a striking co-localization between LaminB1 and
polyQ aggregates both in the nucleus and in the cytoplasm.
Once LaminB1 is exported into the cytoplasm, it is cleaved
and degraded through two independent pathways, the auto-
phagy-lysosome and GOMED-like systems. A small portion is
excreted also in healthy cells. However, when the canonical
autophagy-lysosome pathway is impaired, the cytoplasmic
LaminB1 is increasingly channeled for excretion, together with
p62 in large microvesicles or exophers [44].
We hypothesize that this excretion process is a clearance
mechanism for the cell, alternative to lysosomal and Golgi-medi-
ated degradation; however, with the potential consequence of
causing cell and tissue atrophy. While the function of the basal
excretion of LaminB1-rich buds remains to be understood, the
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exacerbated excretion under autophagy and Golgi impairment
represents a novel mechanism for cell atrophy and death. In
absence of effective degradation and recycling of the basic com-
ponents, this process depletes the cell of material, damaging its
nucleus and cytoplasm and leaving behind cell corpses with a
fragile nucleus and thin cytoplasmic layer. In our experiments,
in vivo and in vitro, cytoplasmic accumulation and excretion of
LaminB1 correlated with an increase in cell death, misshapen
nuclei, and cell atrophy.
The common factor underling this mechanism of cell atrophy
and death is a persistent block in autophagy. Since chronic auto-
phagy inhibition has been reported in an increasing number of
rare and common human neurodegenerative pathologies, the
mechanism here reported may therefore be of great relevance
in human disease.
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Antibodies
rabbit a-Lamp2a Abcam Cat#ab18528; RRID: AB_775981
mouse a-p62 Abnova Cat#H00008878-M01; RRID: AB_548364
rabbit a-LaminB1 Abcam Cat#ab16048; RRID: AB_10107828
mouse a-GM130 BD Transduction Lab, Cat#010823; RRID: AB_398142
mouse a-PolyQ Chemicon Cat#MAB1574; RRID: AB_94263
mouse a-dmLaminB DSHB Cat#ADL67.10; RRID: AB_528336
mouse a-g-H2AX Millipore Cat#05-636; RRID: AB_309864
rabbit a-TFEB Bethyl Labs Cat#A303-673A; RRID: AB_11204751
rabbit a-Atg5 Novus Biological Cat#NB110-53818; RRID: AB_828587
rabbit a-Atg13-P-S318 Rockland Cat#600-401-C49S (Lot
27919); RRID: AB_11181153
rabbit a-phospho-p70S6K Cell Signaling Cat#9205S; RRID: AB_330944
mouse a–a-tubulin SIGMA Cat#T9026; RRID: AB_477593
chicken a-MAP2 Abcam Cat#ab5392; RRID: AB_2138153
Chemicals, Peptides, and Recombinant Proteins
Bafilomycin A1 SIGMA Cat#B1793
Rapamycin Calbiochem Cat#553210
Brefeldin A SIGMA Cat#B7651
Lipofectamine3000 reagent Invitrogen Cat#L3000-008
TRI Reagent Invitrogen Cat#T9424
SuperScript III Reverse Transcriptase Invitrogen Cat#18080-051
Critical Commercial Assays
UPL library Roche N/A
TaqMan Universal PCR Master mix ThermoFisher Scientific Cat#4304437
SuperSignal West Pico Chemiluminescent Substrate ThermoFisher Scientific Cat#34080
Experimental Models: Cell Lines
SK-N-BE(2) ATCC ATTC: CRL-2271
Experimental Models: Organisms/Strains
Mouse: C3;B6-Tg(Prnp-ATN1)84Dbo/Mmmh MMRRC repository RRID: MMRRC_000396-MU
Mouse: C3;B6-Tg(Prnp-ATN1)150Dbo/Mmmh MMRRC repository RRID: MMRRC_000398-MU
Mouse: B6CBAF1/OlaHsd Harlan Olac, Bicester, UK N/A
Mouse: B6.Tg(CAG-GFP-LC3) [18] MTA G. Bates
D. melanogaster: Elav-Gal4;Repo-Gal4,ubi-Gal80ts This paper N/A
D. melanogaster: UAS-LacZ BDSC #8529
D. melanogaster: UAS-sAtro75QN. [14] N/A
Epg5 p.Phe1604Glyfs*20 fibroblasts [21] N/A
Human fibroblasts DRPLA17 Corriell Coriell: GM13717
Human fibroblasts DRPLA16 Corriell Coriell: GM13716
Human fibroblasts control, m, 51 MRC CNMD Biobank
London
UN3373
Human fibroblasts control, m, 3 [21] N/A
Oligonucleotides
Atg5 siRNA (50-GGU UUG GAC GAA UUC CAA CUU GUU U-30) Eurofins Genomix; [45] N/A
Atg6 siRNA (50-ACA GUG AAU UUA AAC GAC AGC AGC U-30) Eurofins Genomix; [45] N/A
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Manolis
Fanto (manolis.fanto@kcl.ac.uk).
EXPERIMENTAL MODELS AND SUBJECT DETAILS
Drosophila
The followingmutant fly stocks were used: Elav-Gal4, Repo-Gal4, ubi-Gal80ts, UAS-LacZ, UAS-sAtro75QN. Elav-Gal4;Repo-Gal4,ubi-
Gal80ts virgin females were crossed tomales from theUAS-LacZ andUAS-sAtro75QN stocks. After development at 18C the F1 prog-
eny was transferred to 29C. 14 days old females were used for immunofluorescence.
Animals
All experimental procedures involvingmice were carried out under a license from the HomeOffice according to regulations set by the
Animals (Scientific Procedures) Act 1986 (ASPA). Reporting of animal experiments is in accordance to the ARRIVE guidelines [48].
The two DRPLA mouse strains C3;B6-Tg(Prnp-ATN1)84Dbo/Mmmh (26Q) and C3;B6-Tg(Prnp-ATN1)150Dbo/Mmmh (65Q) [12]
were recovered from theMMRRC repository andmaintained by backcrossing to (CBA/Ca xC57BL/6J)F1 animals, B6CBAF1/OlaHsd
(Harlan Olac, Bicester, UK), often used to analyze behavior in the R6/2 HDmouse models [49]. The double mutants heterozygous for
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
non-specific control siRNA (50-AGG UAG UGU AAU CGC CUU G-30,
47%CG)
Eurofins Genomix N/A
Primer: Hprt1 Forward: cctcctcagaccgcttttt Reverse: aacctggttcatcat
cgctaa UPL: 95
This paper N/A
Primer: b-actin Forward: aaggccaaccgtgaaaagat Reverse: gtggtacgac
cagaggcatac UPL: 56
This paper N/A
Primer: Tfeb Forward: gagctgggaatgctgatcc Reverse: gggacttctgca
ggtcctt UPL: 22
This paper N/A
Primer: Hprt1 Forward: tgatagatccattcctatgactgtaga Reverse: aagacat
tctttccagttaaagttgag UPL: 22
This paper N/A
Primer: Ctsb Forward: cttgctgtggtatccagtgtg Reverse: cacctgaaacca
ggccttt UPL: 50
This paper N/A
Primer: Prkag Forward: ctgtcagacatcctgcaagc Reverse: ctacattcacgg
cggtcat UPL: 62
This paper N/A
Primer: Bip Forward: gccaactgttgtaacaatcaaggtct Reverse: tgacttcaatct
ggggaactc
This paper N/A
Primer: Chop Forward: tccgcagcaggtgcag Reverse: tcctcataccaggctt
cca
This paper N/A
Primer: Xbp1 Forward: gccaactgttgtaacaatcaaggtct Reverse: ccaacttg
tccagaatgccc
This paper N/A
Recombinant DNA
p(RFP)-EGFP-LC3B [46] N/A
mCherry-LaminB1-10 gift from Michael
Davidson
Addgene plasmid: #55069
Software and Algorithms
EthoVision 7XT Noldus, Netherlands N/A
Green and Red Puncta Colocalization macro, ImageJ [47] http://imagejdocu.tudor.lu/doku.php?
id=plugin:analysis:colocalization_
analysis_macro_for_red_and_green_
puncta:start
Columbus PerkinElmer, Hamburg N/A
Image Studio Lite Li-Cor https://www.licor.com/bio/products/
software/image_studio_lite/
GraphPad Prism GraphPad Software https://www.graphpad.com/
how-to-buy/
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GFP-LC3 and DRPLA were achieved by crossing ATN1-FL-26Q-84 and ATN1-FL-65Q-150 lines to the B6.Tg(CAG-GFP-LC3) [18]
autophagy reporter line. Genotyping was performed by PCR using ear biopsies. Primers: PrP- FW: 50-CTCTTTGTGACTATGTG
GACTGATGTCGG-30, PrP-RV: 50-GTGGATACCCCCTCCCCCAGCCTAGACC-30, At-3818: 50-GGTGGGGAGGTGGCGAGGAT-30,
GFP(LC3): 50-TCCTGCTGGAGTTCGTGACCG-30, and LC3*rc3: 50-TTGCGAATTCTCAGCCGTCTTCATCTCTCTCTCGC-30. PCR
conditions were 95C for 30 s, 58C for 30 s, and 72C for 60 s for a total of 34 cycles. Animals were housed under 12 h light/
12 h dark cycle (7am to 7pm light), with unlimited access to water and food (Special Diet Service, Witham, UK) in a conventional
unit. All animals were immunocompetent and drug naive. Cages were environmentally enriched with a cardboard hut, tube, and
bale of shredded paper. The wild-type, ATN1-FL-26Q, and ATN1-FL-65Q were kept in separate cages with 4-6 animals per cage.
6 groups of mice with 8-10 animals per genotype and gender were exposed to repetitive behavioral testing from four weeks of
age in the hours 13:00–17:00 on same days of the week. The double-, single- and non-transgenic animals were selected from the
same litters, hereby preferably selecting the wild-type control littermates from the heterozygous ATN1-FL-65Q to GFP-LC3 crosses.
Grip strength and rotarod performance were tested every four weeks. Open-field experiments were performed at 10 weeks for both
sexes as well as at 14 weeks for females only. The mice were separated in two rounds consisting of 13 experimental units for rotarod
performance. Females were tested prior to males. For open field the mice were randomly distributed into the four experimental
arenas with all three genotypes represented at a time. The behaviorally assessed animals were repurposed for further phenotyping
procedures, such as morphological and biochemical analysis after reaching the end-stage (Supplemental table S1). The end-stage
was defined as 20 weeks for males and 24 weeks for females using the distress scale.
Cell culture
Human fibroblasts DRPLA17 (Corriell GM13717, male, age 47, 65Q), DRPLA16 (Corriell GM13716, male, age 15, 68Q), age matched
control to DRPLA17 (male, age 51), Vici syndrome fibroblasts (Epg5 p.Phe1604Glyfs*20, male, age 3), age matched controls to Vici
syndrome (male, age 3) [21] are derived from skin biopsies. Human neuroblastoma cell line SK-N-BE(2) was purchased from ATTC
(CRL-2271). This brain neuroblasts are derived originally from a bone marrow metastasis of 2 year old male individual. All cells were
cultured in DMEM high glucose with 10% (v/v) FCS, 1 mM sodium-pyruvate, penicillin/ streptomycin and L-Glutamine.
METHOD DETAILS
Behavioral analysis
Rotarod performance
Motor coordination was tested on an accelerating rotarod, by placing mice individually on an accelerating, rotating beam (4-40 rpm)
for amaximumof fivemin as previously described [50]. Latency to fall was recorded as time (sec) themousewas able to remain on the
beam.Micewere exposed consecutively to three trials per daywith two habituation and two experimental days at four weeks age and
one habituation and two experimental days for following stages. The mice were separated in two rounds consisting of 13 experi-
mental units. Animals of each unit were of the same genotype and age housed in one numbered cage. The experimenter was blind
to the genotype of the experimental animals and units coded by numbers. Females were tested prior to males. The apparatus was
thoroughly cleaned using 70% ethanol after each trial. The averages from replicates from three experimental trials and two exper-
imental days were calculated for each animal and subjected to statistical analysis (n = 8-10).
Grip strength
Grip strength capacity was assessed as previously described on the habituation day prior to the rotarod performance analysis [51].
Three independent measurements of the strength of the forelimbs only, as well as fore- and hind limbs taken together were averaged
as technical replicates. Mice were guided along wire-mesh grid attached to a grip strength monitor (Bioseb In Vivo Research Instru-
ments) by holding them at the base of the tail. Mice were either allowed to grip with forelimbs only, or fore- and hind limbs together.
The maximum tension was recorded (g) by gently pulling the mouse away from the apparatus. Females were tested prior to males.
The experimenter was blind to the genotype of the experimental animals coded by numbers. The averages from replicates of the
three experimental trials were calculated for each animal and subjected to statistical analysis (n = 8-10).
Open field
The locomotive behavior was analyzed by placing mice individually into square, plain white open field arenas (503 503 50 cm, En-
gineering & Design Plastics, Cambridge, UK) for 30 min. The spatiotemporal position of the individual animal was recorded through a
video camera positioned above the apparatus and respective individual trails were tracked and later analyzed using EthoVision 7XT
software (Noldus, Netherlands) as previously described [51]. Exploratory activity in a novel, unfamiliar environment was assessed as
the distance traveled (cm) over the total area in the first five min after introduction to the open field. Thigmotaxis, the time (s) spent in
the peripheral, outer-zone of an open field is indicative of an anxiety-like behavior [16], and was analyzed likewise during the first five
min after introduction to the novel environment. The open field arena was divided into two square zones, with outer zone 503 50 cm
and inner zonewith 403 40 cm. The general activity was analyzed between five and 25min after the introduction to the open field as a
distance traveled (cm) during the given 20 min interval. The mice were randomly distributed into the four experimental arenas with all
three genotypes represented at a time. The open field arena was thoroughly cleaned using 70% ethanol after each trial.
Gait analysis
For the gait analysis non-toxic finger paint was applied on the front (blue) and back (red) paws of the mice and the mice were allowed
to walk through a transparent corridor (5 cm x 1 m) toward a dark chamber.
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Transmission electron microscopy
The single transgenic DRPLA mice were transcardially perfused with physiological saline solution followed by filtered 2.5% (v/v) EM
grade glutaraldehyde and 2% (v/v) EM grade paraformaldehyde in 0.1cM sodium cacodylate buffer. The dissected brains were post-
fixed for 24 h and kept at 4C in 0.1cM sodium cacodylate buffer until further processing. 120 mm thick vibratome slices were post-
fixed in 1% (v/v) osmium tetroxide in 0.1cM sodium cacodylate buffer, followed by en bloc contrasting in 1% (w/v) uranyl acetate for
45 min. The coronal brain slices were gradually dehydrated in ethanol and propylene oxide and finally infiltrated and embedded in
TAAB embedding resin premix (T028H). The resin embedded slices were trimmed to expose the anatomic region corresponding
to the dentate nucleus and processed at the microtome to retrieve gold sections (90 nm). The ultrathin sections were additionally
contrasted with uranyl acetate and lead citrate and viewed on a FEI Tecnai T12 electronmicroscope operated at 120kV. Images were
acquired with an AMT 16000M camera.
Plasmids and siRNAs
p(RFP)-EGFP-LC3B (gift from P. Codogno), pEGFP-N1, mCherry-LaminB1-10 (Addgene, #55069). The previously published [45]
Atg5 siRNA (50-GGU UUG GAC GAA UUC CAA CUU GUU U-3), Atg6 siRNA (50-ACA GUG AAU UUA AAC GAC AGC AGC U-30)
and non-specific control siRNA (50-AGG UAG UGU AAU CGC CUU G-30, 47%CG) were obtained from Eurofins Genomix and lyoph-
ilized in supplied RNAmax buffer.
Cell culture treatments and autophagy flux analysis
Treatment with 1mMRap, 10 nMBafA1 and 0.1% of solvent DMSO, respectively, were performed for 6, 24, 48 or72 hr for assessment
of autophagy flux. For analysis of LaminB1 accumulation and end excretion cells were treated for 24 hr with DMSOor BafA1, followed
by replacement of the mediumwith DMSO, BafA1, 1 mMBrefA or BafA1/BrefA combination after rinsing with PBS. Cells were fixed in
4% paraformaldehyde for 15 min and washed in PBS. The immunocytochemical evaluation was performed in 96-well plate format
using Opera Phenix system andColumbus software. Cells were transiently transfected using Lipofectamine3000 reagent (Invitrogen)
according to the manufactures protocol. For assessment of autophagy flux fibroblasts were starved in HBSS or treated with 10 nM
BafA1 for 3 hr and analyzed with life imaging using Nikon Spining disc confocal microscope.
Perfusion and tissue processing
The wild-type, single transgenic or double transgenic mice (n = 6 per group) were transcardially perfused with ice cold physiological
saline solution followed by filtered 4% (w/v) paraformaldehyde in phosphate buffered saline (PBS). The dissected brains were post-
fixed overnight, cryopreserved in 30% (w/v) sucrose in PBS, and embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek). Serial
coronal free floating cryosections were collected at 30 mm thickness using Microm cryostat (Thermo Scientific), and stored in anti-
freeze solution (40% (v/v) PBS, 30% (v/v) Glycerol and 30% (v/v) Ethylenglycol) at 20C until further processing.
Immunohistochemistry and cytochemistry
To avoid nonspecific binding and for permeabilization the sections or fixed cells were incubated in blocking solution (5% (v/v) normal
goat serum, 1% (w/v) bovine serum albumin (BSA), 0.5% (v/v) Triton X-100 in PBS). For somemouse antibodies additional blocking of
endogenous mouse IgGs with 0.1 mg/ml of a-mouse IgG Fab fragments (Zenon Kit, Invitrogen) was necessary. The antibodies were
incubated in carrier solution (1% (v/v) normal goat serum, 1% (w/v) bovine serum albumin (BSA), 0.5% (v/v) Triton X-100 in PBS).
Incubation of primary antibodies was performed for 48 hr at 4C on an orbital shaker. Secondary antibodies were applied for 4 hr
at room temperature. Primary antibodies: mouse a-GFP (1:500, Roche), rabbit a-GFP (1:5000, Life technologies, A11122), rabbit
a-Lamp2a (1:2000, Abcam, ab18528), mouse a-p62 (1:2000, Abnova, H00008878-M01), rabbit a-LaminB1 (1:1000, Abcam,
ab16048), mouse a-GM130 (BD Transduction Lab, 010823), mouse a-PolyQ (1:1000, Chemicon, IC2), mouse a-dmLaminB
(1:500, DSHB), chicken a-MAP2 (1:1000, Abcam, ab5392), mouse a-gH2AX (1:1000, Millipore), rabbit a-TFEB (1:200, Bethyl
Labs). A555,A488 or A633 conjugated goat a-mouse, a-rabbit or a-chicken secondary antibodies (1:500, Invitrogen) were used.
To remove lipofuscin-like autofluorescence the stained sections were bleached with 10 nm CuSO4 in ammonium acetate buffer
(pH = 4.8) for 20 min [52] without affecting the specific antibody staining (Figure S2). To reveal the cell nuclei fluorescent dye Hoechst
33342 was applied in a concentration of 0.1 mg/ml in PBS for five min. Slices were mounted on microscopic slides in fluorescent
mounting medium (DAKO). Confocal images of 40 to 90 cells were taken from 3 to 6 animals and analyzed morphometrically with
experimenter being blinded to the genotype. Cells were imaged directly in multiwell plates in PBS and subjected to automated
morphometric analysis.
Western blot analysis
In vivo brain lysates
Double transgenic mice (three per genotype and stage) were sacrificed by cervical dislocation followed by decapitation. The brains
were dissected in ice cold PBS under a stereomicroscope. The two forebrain hemispheres were separated bymedio-sagittal incision
and detached form the diencephalon by an inclined cut to separate connecting fibers. The cerebellumwas separated by disruption of
cerebellar peduncles. The remaining parts comprising diencephalon, midbrain, pons, and formatio reticularis are referred to as the
brainstem. The tissue was deep frozen in liquid nitrogen and stored at 80C. The tissue was homogenized in modified RIPA
buffer (137 mM NaCl, 20 mM Tris-HCl pH 7.5, 25 mM sodium glycerophosphate, 2 mM EDTA, 1 mM sodium-orthovanadate, 1%
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(v/v) IGEPAL CA-630, 1% (w/v) deoxycholate, supplemented with Complete protease inhibitor cocktail (Roche)) using plastic pestles
followed by three times repeated freezing in liquid nitrogen and thawing on ice. The supernatant was retrieved by 15 min centrifuga-
tion at full speed in Haereus Biofuge fresco (40474211, Kendro, rotor # 3328) cooled to 4C. The pellet consisting of white top un-
constrained fraction and transparent agglutinated bottom fraction was resuspended in homogenization buffer and homogenized
by sonication (Brandelin Sonoplus UW2070).
Whole-cell lysates
Human fibroblast cultures were rinsed with PBS, lysed in modified RIPA buffer, scraped from the Petri dish incubated for 15 min on
ice and centrifuged for 15 min at 4C. Supernatants were subjected to analysis. The experiment was repeated three times on three
independent days (n = 3). The lysates from the three independent experiments were loaded on one SDS-PAGE gel and densitometric
evaluation of the western blot analysis was performed on the resulting triplicates.
Excretion analysis
Extracellular vesicle isolation via gradual ultracentrifugation and cytoplasmic and nuclear preparation were performed as described
in [53]. Medium was removed from the cells and subjected to three centrifugation steps at 300 g, 10,000 g and 100,000 g at 4C. The
final pellet was washed in PBS and lysed in 1x Laemmli buffer. The results of from five independent experiments were subjected to
statistical analysis.
Nuclear and cytoplasmic preparations
after aspiration of the medium the cells were washed in ice-cold PBS, detached with Trypsin-EDTA, washed in PBS and harvested in
hypoosmotic homogenization buffer (10mMHEPES, 10mMKCl, 0.1mMEDTA, 0.1mMEGTA, 2mMDTT, 25mMNaF, 1mMNaVO3,
PhosStop (Roche Applied Science), Complete protease inhibitor mixture (Roche Applied Science)). After incubation on ice for 15min,
the cells were lysed by the addition of 0.6% (v/v) Igepal CA-630 and vigorous vortexing. After centrifugation, the supernatant repre-
senting the cytoplasmic fraction was saved. The nuclear pellet was washed twice in homogenization buffer containing 0.6% (v/v)
Igepal. The supernatant of the two washes was added to the cytoplasmic fraction. The nuclear pellet was dissolved by sonication
in modified RIPA buffer. The results from five independent experiments subjected to western blot analysis were evaluated
statistically.
SDS-PAGE and western blot assay
Protein concentration was determined using BCA assay kit (ThermoFischer Scientific) according to the manufacturer’s protocol us-
ing a microplate reader at 495 nm. The protein lysates were denaturated in Laemmli buffer for 5 min at 95C, followed by separation
using SDS-PAGE by loading 100 mg of supernatant protein and 50 mg of pellet protein, respectively, and transferred onto nitrocellu-
losemembrane (ECL, 0.2 mmpore size, Amersham) using BioRadMini-Protean andMini-Trans-Cell systems. Unspecific binding was
blocked with 5% (w/v) low-fat milk powder or 5% (w/v) BSA in Tris-buffered saline supplemented with 0.1% (v/v) tween (TBST). The
primary antibodies were incubated in blocking solution overnight at 4C. Primary antibodies: mouse a-GFP (1:1000, Roche), rabbit
a-LC3 (1:5000, MBL, PD014), mouse a-p62 (1:5000, Abnova, H00008878-M01), rabbit a-phospho-p70S6K (1:1000, Cell Signaling,
9205S), rabbit a-Atg5 (1:500, Novus Biological), rabbit a-Atg13-P-S318 (1:2000, Rockland) andmouse a–a-tubulin (1:20000, SIGMA,
T9026). The HRP conjugated secondary a-mouse and a-rabbit antibodies (1:2500, Calbiochem). The a-LC3 antibody recognized the
classic doublet for GFP-LC3 in the supernatant, but only the lower band, corresponding to LC3-II, was detected in the pellet of in-vivo
tissue lysates (Figure S4B). Themouse a-GFP antibody only recognized this lower band in both supernatant and pellet of in vivo tissue
lysates (Figure S4B). Secondary antibodies were incubated in 5% (w/v) low-fat milk powder in TBST for 1 h at room temperature. All
specific signals were detected at the predicted molecular weight according to the molecular weight marker using SuperSignal West
Pico Chemiluminescent Substrate (ThermoFisher Scientific). The densitometric analysis was performed using Image Studio Lite soft-
ware (Li-Cor).
RNA extraction and quantitative RT-PCR
The cerebellum was dissected from wild-type, 26Q and 65Q mice (n = 6). The tissue was snap frozen in liquid nitrogen and stored
at 80C. The phenol/chlorophorm RNA extraction was performed using TRI Reagent (Invitrogen) according to the manufacturer’s
protocol. cDNA was generated using SuperScript III Reverse Transcriptase (Invitrogen). To quantify expression levels of Tfeb, cDNA
template was amplified using UPL-based (UPL library, Roche) qPCR in combination with TaqMan Universal PCR Master mix on ABI
7900HT real-time PCR system (Applied Biosystems). For quantification (averages from triplicates) of expression levels of ER stress
response and Tfeb target genes real-time qPCR was performed using the Light Cycler 480 system (Roche Applied Science, Indian-
apolis, IN, USA) as previously described [54]. All sequences used for the quantification are listed in the Key Resources Table.
QUANTIFICATION AND STATISTICAL ANALYSIS
Morphometric analysis
For Golgi size, H2AX, LaminB1, GFP-LC3, Lamp2a and GFP-RFP-LC3 puncta quantification was performed using ImageJ software.
Confocal images of 40 to 90 cells from 3 to 6 animals were subjected to background subtraction, automatic thresholding (default and
rely entropy, respectively) and particle analysis. For particle area, size, and number, ‘analyze particles’ command on binary images
was applied. For intensity values gray level images were assessed after background subtraction. Colocalization analysis performed
using images from the ‘Green and Red Puncta Colocalization’ macro [47]. Lipofuscin quantification was performed manually using
the cell counter tool in ImageJ. The automated quantification of LaminB1 inclusions in the cytoplasmwas performed using Columbus
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software. The cellular regions were defined using functions such as find nuclei (Hoechst), find cytoplasm (LaminB1 background or
EGFP) and find surrounding region for extracellular LaminB1 spots. Select population was applied to analyze whole cells only or
to separate EGFP-positive from untransfected non-EGFP positive cells. The nuclear shape was analyzed using STAR shape analysis
(area, roundness). Find spots function was employed for detection of LaminB1 or p62 specifically in the cytoplasm region as puncta
per cell or, in cases of varied puncta size, area occupied by puncta per cell. The analysis was performed in at least 3 or 5 replicates
including random selection of 20-40 imaging fields with multiple cells.
Statistical analysis
All quantifications were donemanually in blind, unless otherwise stated. Statistical analysis was performed usingMicrosoft Excel and
GraphPad Prism software. The data were tested for normality and equal variances using two-sided Z-test and F-test function in Excel
as well as column statistics and Kolmogorov-Smirnov test in GraphPad prism. Subsequent comparison of differences between
groups (genotypes, treatments) was assessed with adequate parametric and non-parametric tests for two group (Student’s t test,
Mann-Whittney) or multiple group comparisons (one-way ANOVA, Kruskal-Wallis). For comparison of two variables, e.g., genotype
and treatment, at a time (variable1 = v1, variable2 = v2) two-way ANOVA was employed.
For animal experiments power calculations were not performed due to the exploratory nature of this study. Behavioral data were
tested for significant differences using repeated-measures two-way ANOVA, thereby separating males (nR 8) and females (nR 8),
since the values of control animals varied significantly between sexes. No significant differences were detected between the animals
from the two rounds behavioral analysis, nor animals expressing GFP-LC3 in addition to ATN1 transgene. In the histological and
qPCR analysis no differences between males (n = 3) and females (n = 3) were evident. Therefore statistical significances were
analyzed between mixed gender groups using one-way ANOVA, unless otherwise stated. For western blot assays the densitometric
data (males, n = 3) was analyzed using unpaired Student’s t test, unless otherwise stated.
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